Ep. 23 : Group Administration of Psychedelics: An  Interview with Chris Stauffer - podcast episode cover

Ep. 23 : Group Administration of Psychedelics: An Interview with Chris Stauffer

Jun 23, 20221 hr 5 minSeason 2Ep. 23
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Dr. Chris Stauffer talks about his research investigating the use of group-administered psilocybin and MDMA. The advantages of group administration are discussed, including the opportunity to increase social connection and deepen capacities to be vulnerable with others. Dr. Stauffer also highlights how group psychedelic-assisted therapy needs to be adapted to the identities of the participants, sharing about his experiences in working with the veteran population and a study with transgender and gender non-conforming participants. Chris also discusses his work on oxytocin and how that influences the way the thinks about increased social connection as a process of change involved in psychedelic-assisted therapy.

Mentioned in the show:

Rat Park Study: https://www.psychiatrictimes.com/view/what-does-rat-park-teach-us-about-addiction

MDMA and Critical Periods: https://hub.jhu.edu/2019/04/04/mdma-opens-critical-period-for-social-behavior/

https://www.chrisstauffermd.com/

For the best experience, listen in Metacast app for iOS or Android